These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Combination therapy with indinavir, ritonavir, and delavirdine and nucleoside reverse transcriptase inhibitors in patients with HIV/AIDS who have failed multiple antiretroviral combinations. Grodesky M, Acosta EP, Fujita N, Mason S, Gerber JG. HIV Clin Trials; 2001 Dec 26; 2(3):193-9. PubMed ID: 11590527 [Abstract] [Full Text] [Related]
8. Pharmacokinetics of reduced-dose indinavir/ritonavir 400/100 mg twice daily in HIV-1-infected Thai patients. Boyd M, Mootsikapun P, Burger D, Chuenyam T, Ubolyam S, Mahanontharit A, Sangkote J, Bunyaprawit P, Horsakulchai M, Lange J, Cooper D, Phanuphak P, Ruxrungtham K. Antivir Ther; 2005 Dec 26; 10(2):301-7. PubMed ID: 15865224 [Abstract] [Full Text] [Related]
11. Ritonavir/saquinavir plus one nucleoside reverse transcriptase inhibitor (NRTI) versus indinavir plus two NRTIs in protease inhibitor-naive HIV-1-infected adults (IRIS study). Florence E, Dreezen C, Desmet P, Smets E, Fransen K, Vandercam B, Pelgrom J, Clumeck N, Colebunder R. Antivir Ther; 2001 Dec 26; 6(4):255-62. PubMed ID: 11878407 [Abstract] [Full Text] [Related]